Big pharma largely stole the show throughout the course of the past year, but a number of small- and mid-cap NASDAQ pharma stocks have also ... million Share price: US$3.31 Chimerix is a clinical ...

Consequently, shares not tendered were converted to cash and CVRs, Lumos Pharma's stock will be delisted from NASDAQ, and they will continue operating under DPV ... price of $3.95 on October ...